UNSPSC 51285907: Methenamine mandelate

This classification denotes a urinary anti-infective agent with the molecular formula C8H8O3.C6H12N4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 695N30CINR, chemically known as 1,3,5,7-tetraazatricyclo(3.3.1.1(3,7))decane, mono(alpha-hydroxybenzeneacetate) but more generally known as methenamine mandelate, which bears US NIH Compound Identifier 11478. European Medicines Agency schedules Methenamine mandelate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB03216MIG.

SMILES: OC(C1CCCCC1)C(=O)O.N12CN3CN(CN(C3)C2)C1.

UNSPSC 51285907 Methenamine mandelate is a Commodity code representing individual pharmaceutical products procured by state and local health authorities. Based on recent solicitations, state and local governments buy specific branded and generic pharmaceuticals—including antibiotics, emergency medications, and drug-management systems—through piggyback contracts, cooperative purchasing consortia, and competitive bidding. The issuing bodies are primarily state health departments and county health agencies using established pharmaceutical supply agreements or direct procurement to support public health operations, emergency preparedness, and community health initiatives.

Recent activity centers on Florida and Illinois. The Illinois Department of Public Health awarded a $2,999,999.11 piggyback pharmaceutical contract through the MMCAP Infuse consortium to Chartwell Rx LLC in August 2026 for antibiotic supply (Doxycycline Hyclate 100mg and Ciprofloxacin Hydrochloride 500mg tablets) with a 12-month initial term and renewal options. Seminole County, Florida issued an IFB in June 2026 seeking 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually through quarterly deliveries to the Seminole County Community Health Building; the response deadline was July 26, 2023 (a historical date in the record), with FEMA funding involvement and federal compliance requirements including the Clean Air Act and Federal Water Pollution Control Act. Neither procurement specified set-aside designations for disadvantaged enterprises. The code shows activity driven by state-level health department purchasing and county-level community health procurement, typically structured as multi-year agreements with renewal options and quarterly or annual delivery schedules.